Studi Penggunaan Obat Golongan Beta-Blocker Pada Pasien Rawat Inap Rumah Sakit Ansari Saleh Banjarmasin

Okta Muthia Sari

doi:10.24843/JFU.2020.v09.i02.p07

Okta Muthia Sari Universitas Lambung Mangkurat

DOI: https://doi.org/10.24843/JFU.2020.v09.i02.p07

Abstract

Beta-blockers have a role in cardiovascular and non-cardiovascular therapy. Many beta-blockers are now available and in general they are all equally effective. There are, however, differences between them, which may affect choice in treating particular diseases or individual patients. Research related to the profile of beta-blocker drug use in cardiovascular and non-cardiovascular therapy is still limited. This study aims to describe the use of beta-blockers in inpatients at Ansari Saleh Hospital, Banjarmasin. This retrospective descriptive study was conducted from April to May 2019 at the Anshari Saleh Hospital, Banjarmasin. The beta-blocker drugs used were bisoprolol and propranolol which were administered in cardiovascular medications such as angina (3.7%); arrhythmia (3%); Congestive Heart Failure (20%); hypertension (3%); myocardial infarction (54.8%); non hemorrhagic stroke (9.6%); and non-cardiovascular including hepatic cirrhosis (1.5%); hyperthyroidism (4.4%). The bisoprolol dosage used by inpatients at Ansari Saleh Hospital starts from 1.25 to 5 mg per day. Myocardial infarction and non-hemorrhagic stroke patients received bisoprolol dose uptitration. The propranolol dosage is 20-30 mg per day. In cardiovascular patients, bisoprolol is a drug that is often given to patients with comorbids than propranolol.

Keywords: Beta-blockers, cardiovascular, non-cardiovascular, therapy

Downloads

Download data is not yet available.

References

Aberg, J. A., Lacy, C. F., Amstrong, L. L., Goldman, M. P., & Lance, L. L. (2009). Drug Information Handbook 17th edition. Lexi-Comp for the American Pharmacists Association.
Aberg, J. A., Lacy, C. F., Amstrong, L. L., Goldman, M. P., & Lance, L. L. (2011). Drug Information Handbook 20th edition. Lexi-Comp for the American Pharmacists Association.
Amalia, A. R. (2014). Studi Penggunaan Bisoprolol pada Pasien Infark Miokard Akut (Penelitian di RSUD Dr. Saiful Anwar Malang) [Skripsi]. Universitas Muhammadiyah Malang.
Angeli, P., Bernardi, M., Villanueva, C., Francoz, C., Mookerjee, R. P., Trebicka, J., Krag, A., Laleman, W., & Gines, P. (2018). EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Journal of Hepatology, 69(2), 406–460. 10.1016/j.jhep.2018.03.024.
BNF. (2018). British National Formulary 76th Edition. BMJ Group.